Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study

Article ID	Journal	Published Year	Pages	File Type
6200858	Ophthalmology	2016	6 Pages	PDF

Abstract

Diabetic macular edema patients with VMA have a greater potential for improvement in visual outcomes with anti-vascular endothelial growth factor therapy. Therefore, the presence of VMA should not preclude patients with DME from receiving treatment.

Keywords

VMA DME Crt AMD ERM VMT BCVA PVD Diabetic macular edema Oct best-corrected visual acuity Optical coherence tomography posterior vitreous detachment Spectral domain age-related macular degeneration central retinal thickness epiretinal membrane Vascular endothelial growth factor Vascular Endothelial Growth Factor (VEGF)vitreomacular adhesion vitreomacular traction

Related Topics

Health Sciences Medicine and Dentistry Ophthalmology

Preview

Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study

Authors

Mohammad Ali MD, Mohamed Kamel MD, Salman MD, Aniruddha MD, Mostafa MD, Sibel MD, Zubir S. MSc, Waqar Khan, Diana V. MD, Quan Dong MD, MSc, Yasir J. MBBS, READ-3 Study Group READ-3 Study Group,